Leaders of various countries said that the “miracle” of vaccine research and development does not mean that the epidemic is expected to end. Although many countries have launched their own COVID-19 vaccination plans, new variant viruses have emerged. Therefore, to end the epidemic, new ones are still needed. Boost.
In the face of the increasingly severe coronavirus epidemic, leaders of all countries on Friday called for an investment of US$19 billion in funding to find more tools to end this prolonged epidemic.
They said that the “miracle” of vaccine research and development does not mean that the epidemic is expected to end. Although many countries have launched their own COVID-19 vaccination plans, new variant viruses have emerged. Therefore, to end the epidemic, new assistance is still needed. thrust.
At a press conference held by the World Health Organization on Friday, French President Macron said: “We must not let the virus get out of control in the entire region… The emergence of new variants of the virus shows that our health still depends on the poorest countries. So there is still a lot of work to be done.”
European Commission President Von der Lein called on more countries to join. She said that the epidemic is far from over. What is needed now is to increase the production of vaccines and deliver them to all parts of the world.
Under the leadership of the World Health Organization, in April last year, countries established the ACT Accelerator (ACT Accelerator) to respond to the epidemic. The goal is to develop, produce and equitably distribute COVID-19 vaccines, diagnosis and treatment methods. The plan seeks US$22 billion in funding this year to continue to overcome the epidemic, but there is still a funding gap of US$19 billion.
WHO Director-General Tedros Adhanom Ghebreyesus reminded at a press conference on Friday that leaders of all countries are now faced with a choice, that is, to invest funds now to deal with the root cause of the virus ravaged the world, or continue to solve the consequences of the epidemic. The end cost trillions of dollars. Tan Desai said: “We can only end the COVID-19 epidemic if we fund, share and expand epidemic prevention tools.”
Tan Desai reiterated the problem of uneven distribution of vaccines. He pointed out that nearly 900 million doses of vaccines have been vaccinated worldwide, but more than 81% of vaccinations have been carried out in high-income or middle- and high-income countries, and only 0.3% have been carried out in low-income countries.
The WHO and the Global Alliance for Vaccines and Vaccinations have also established the “Coronary Disease Vaccine Global Access Mechanism” (COVAX) to promote vaccine multilateralism so that poor countries can also obtain vaccines. This donor-funded mechanism has delivered more than 40.5 million doses of vaccine to 118 countries and regions. It plans to provide at least 2 billion doses of vaccine this year, of which 1.3 billion doses will be supplied to 92 of the world’s poorest countries.
Macron said that France will provide 500,000 doses of vaccine to COVAX within a few months and hopes other countries will do the same.
African countries are in urgent need of vaccines, but they lack relevant technologies. South African President Rampsa called on pharmaceutical companies to temporarily “remove the barriers to intellectual property rights” and share vaccine technology with low- and middle-income countries so that more countries can produce their own vaccines.